Sun Yat-sen University clinical trial pipeline

16 trials changed in the last 30 days: 2 stopped, 3 with notable changes, 11 with minor changes only.

1. Stopped

   Validation of Insulin Dose Prediction Model Based on Artificial…Validation of Insulin Dose Prediction Model Based on Artificial Intelligence Algorithm

   Trial terminated

   Also in this update: Final enrollment: 203 participants (planned 400); Primary completion date changed from estimate of Jun 2026 to Dec 5, 2025

   Sun Yat-sen University·Not applicable· NCT07066891· Registry history of NCT07066891 on ClinicalTrials.gov (opens the registry)

   Oct 20, 2026

2. Stopped

   Improving Blood Glucose Homeostasis With Dorzagliatin Tablets…Improving Blood Glucose Homeostasis With Dorzagliatin Tablets · Type 2 Diabetes Mellitus Patients With Moderate to Severe Chronic Renal Insufficiency

   Withdrawn before enrolling

   Sun Yat-sen University·Not applicable· NCT07786571· Registry history of NCT07786571 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

3. Notable

   Penpulimab Combined With GP ± Anlotinib as Neoadjuvant Therapy in…Penpulimab Combined With GP ± Anlotinib as Neoadjuvant Therapy in Locoregionally Advanced Nasopharyngeal Carcinoma

   Primary completion pushed from Jan 1, 2025 to Oct 1, 2026

   Also in this update: Study completion pushed from Jan 1, 2027 to Oct 1, 2028

   Sun Yat-sen University·Phase 2· NCT05193617· Registry history of NCT05193617 on ClinicalTrials.gov (opens the registry)

   Oct 2, 2026

4. Notable

   REPORT-HNSCC · Reduction of Postoperative Radiotherapy in Head…REPORT-HNSCC · Reduction of Postoperative Radiotherapy in Head and Neck Squamous Cell Carcinoma

   Primary endpoint(s) modified

   Also in this update: Enrollment closed, study ongoing

   Sun Yat-sen University·Not applicable· NCT06630780· Registry history of NCT06630780 on ClinicalTrials.gov (opens the registry)

   Sep 30, 2026

5. Notable

   Chidamide With Immunotherapy · Locally Advanced or Metastatic…Chidamide With Immunotherapy · Locally Advanced or Metastatic Urothelial Carcinoma

   Study completion date changed from estimate of Oct 30, 2025 to Aug 18, 2026

   Also in this update: Trial completed

   Sun Yat-sen University·Phase 2· NCT04562311· Registry history of NCT04562311 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.